9-(2-hydroxy-3-nonyl)adenine has been researched along with abt 702 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gotoh, A; Kanno, T; Kuribayashi, K; Nagaya, T; Nakajima, Y; Nakano, T; Nishizaki, T | 1 |
Ito, S; Kon, Y; Otsuguro, K; Otsuka, S; Tomonari, Y; Yamaguchi, S | 1 |
2 other study(ies) available for 9-(2-hydroxy-3-nonyl)adenine and abt 702
Article | Year |
---|---|
Adenosine deaminase inhibitor EHNA exhibits a potent anticancer effect against malignant pleural mesothelioma.
Topics: Adenine; Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Mesothelioma; Mice; Mice, Nude; Morpholines; Pleural Neoplasms; Pyrimidines; RNA Interference; RNA, Small Interfering; Transplantation, Heterologous | 2015 |
An adenosine kinase inhibitor, ABT-702, inhibits spinal nociceptive transmission by adenosine release via equilibrative nucleoside transporters in rat.
Topics: Adenine; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine Deaminase; Adenosine Kinase; Analgesics; Animals; Animals, Newborn; Enzyme Inhibitors; Membrane Potentials; Morpholines; Motor Neurons; Neural Pathways; Nociceptive Pain; Pyrimidines; Reflex; Spinal Cord; Tissue Culture Techniques; Xanthines | 2015 |